What the research shows In the SURMOUNT-1 trial, adults taking once-weekly tirzepatide lost an average of about 15% to 21% of their body weight over 72 weeks depending on dose
Applied neuropsychology
Kuwasako K, Hay DL, Nagata S, Murakami M, Kitamura K, Kato J
If 500 mcg EOD is not producing noticeable effects after a reasonable trial period: Increase to 750 mcg EOD (22.5 units) If still insufficient, increase to 1 mg EOD (30 units) Wait 5 to 7 days between any dose changes to accurately assess your response before adjusting further Do not rush this phase
By embracing a multi-dimensional approach, we can transform the experience of Alopecia Areata from one of frustration and uncertainty into a pathway of healing, self-discovery, and renewed vitality demonstrating that true health lies in the integration of mind, body, and lifestyle
Our focus on high-quality, science-backed ingredients ensures that our community can take control of their health with confidence